Biodexa Pharmaceuticals (BDRX) Shares Outstanding (2013 - 2025)

Biodexa Pharmaceuticals has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $1.1 billion in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 10.77% year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 billion (up 10.77% YoY) and the FY2025 annual result came in at $1.1 billion, up 10.77% from the prior year.
• Shares Outstanding (Entity) climbed to $1.1 billion in Q4 2025 per BDRX's latest filing, from $505.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $16.4 billion in Q2 2024 and troughed at $251709.0 in Q4 2021.
• A 5-year average of $2.1 billion and a median of $500.7 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) jumped 511211.85% in 2023, then slumped 96.92% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $251709.0 in 2021, then increased by 22.71% to $308862.0 in 2022, then surged by 511211.85% to $1.6 billion in 2023, then sank by 37.28% to $990.6 million in 2024, then rose by 10.77% to $1.1 billion in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.1 billion, $505.3 million, and $990.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.